Our site uses cookies to offer a better navigation functionality, including "third party" cookies and "profiling cookies" designed to send on-line commercial communications in line with the preferences expressed by the user while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here to disable them. Upon proceeding with browsing this website, you will be consenting to the use of cookies.

Latest News

A new application for technology used in medicine has been discovered thanks to the collaboration between RIS (Reparto Investigazioni Scientifiche -...
Menarini Ricerche was invited to present an update on MEN1112, a humanized monoclonal antibody targeting CD157, which is co-developed with Oxford Bio...
Today, paediatricians in the region of Liguria in north-west Italy will attend a training and awareness-raising day on the subject of the abuse and i...
According to regional data of the guidelines against the ill-treatment of minors in Puglia, over 6,000 children at risk of neglect and psychological ...
Oncology Alliance between Menarini & Oxford BioTherapeutics Progresses Second Candidate MEN1309 into the Clinic, an Antibody Drug Conjugate for the...
READ ALL NEWS »
CARABINIERI’S CSI DEPARTMENT HAS NEW TECHNOLOGY FOR FIGHTING CRIME

CARABINIERI’S CSI DEPARTMENT HAS NEW TECHNOLOGY FOR FIGHTING CRIME

A new application for technology used in medicine has been discovered thanks to the collaboration between RIS (Reparto Investigazioni Scientifiche - Crime Scene Investigation Department) of the Carabinieri (Italian police) of Rome and Menarini

Company Video Menarini

Quality first

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »